Dr. J. Constipation
Natural health product licensed in Canada
- Other names
- Holy Aloe Vera
- Licence holder
- Holy Land Traditional Medications Inc.
- NPN or DIN-HM
- 80043009
- Status
- Active licence
- Licence date
- 20 June 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aloe vera Source : Latex | 100 mg | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Lécithine, Gélatine, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
(Used in Herbal Medicine for the) short-term relief of occasional constipation. (Traditionally used in Herbal Medicine as a) stimulant laxative. (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Consult a health care practitioner prior to use if you have a kidney disorder, or are taking cardiac medications (e.g. cardiac glycosides or antiarrhythmic medications). Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner if symptoms persist.
Source
Official Health Canada record, licence 80043009
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.